1T-LSD

Chemical compound From Wikipedia, the free encyclopedia

1T-LSD, also known as 1-(thiophene-2-carbonyl)-LSD or as SYN-L-021, is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug.[1][2] It was first identified in Japan in 2023 on blotter paper misrepresented as containing 1D-LSD, but which on analysis was determined to contain 1T-LSD instead.[3] It was also detected in Germany around the same time.[4]

Other names1-(Thiophene-2-carbonyl)-LSD; SYN-L-021
CAS Number
Quick facts Clinical data, Other names ...
1T-LSD
Clinical data
Other names1-(Thiophene-2-carbonyl)-LSD; SYN-L-021
Routes of
administration
Oral
Drug classSerotonergic psychedelic; Hallucinogen
Identifiers
  • (6aR,9R)-N,N-diethyl-7-methyl-4-(thiophen-2-yl)methanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC25H27N3O2S
Molar mass433.57 g·mol−1
3D model (JSmol)
  • O=C(n1cc2C[C@@H]3C(=C[C@H](CN3C)C(=O)N(CC)CC)c3cccc1c32)c1cccs1
Close

Use and effects

A 150 μg dose of 1T-LSD is said to be equivalent to 100 μg LSD.[2] Doses of 87 to 100 μg 1T-LSD have been encountered in blotter tabs.[1]

Interactions

Chemistry

Analogues

Analogues of 1T-LSD include ALD-52 (1A-LSD), 1P-LSD, 1B-LSD, 1V-LSD, 1DD-LSD, and 1T-AL-LAD, among others.

Society and culture

Canada

1T-LSD is not a controlled substance in Canada as of 2025.[5]

United States

1T-LSD is not an explicitly controlled substance in the United States.[6] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

See also

References

Related Articles

Wikiwand AI